H. Lundbeck A/S (HLUBF)
6.40
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
H. Lundbeck Gross Profit Margin (Quarterly) : 79.00% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 79.00% |
| March 31, 2026 | 80.03% |
| December 31, 2025 | 69.59% |
| September 30, 2025 | 85.53% |
| June 30, 2025 | 80.23% |
| March 31, 2025 | 81.37% |
| December 31, 2024 | 70.74% |
| September 30, 2024 | 80.09% |
| June 30, 2024 | 79.87% |
| March 31, 2024 | 80.06% |
| December 31, 2023 | 75.53% |
| September 30, 2023 | 76.88% |
| June 30, 2023 | 76.02% |
| March 31, 2023 | 78.43% |
| December 31, 2022 | 73.80% |
| September 30, 2022 | 78.51% |
| June 30, 2022 | 77.21% |
| March 31, 2022 | 79.60% |
| December 31, 2021 | 75.33% |
| September 30, 2021 | 77.32% |
| June 30, 2021 | 77.15% |
| March 31, 2021 | 76.64% |
| December 31, 2020 | 74.04% |
| September 30, 2020 | 70.38% |
| June 30, 2020 | 76.09% |
| Date | Value |
|---|---|
| March 31, 2020 | 79.58% |
| December 31, 2019 | 74.71% |
| September 30, 2019 | 79.61% |
| June 30, 2019 | 79.77% |
| March 31, 2019 | 79.45% |
| December 31, 2018 | 78.93% |
| September 30, 2018 | 79.75% |
| June 30, 2018 | 79.67% |
| March 31, 2018 | 81.26% |
| December 31, 2017 | 76.91% |
| September 30, 2017 | 77.09% |
| June 30, 2017 | 75.86% |
| March 31, 2017 | 76.13% |
| December 31, 2016 | 73.54% |
| September 30, 2016 | 71.78% |
| June 30, 2016 | 71.63% |
| March 31, 2016 | 70.88% |
| December 31, 2015 | 64.26% |
| September 30, 2015 | 45.35% |
| June 30, 2015 | 63.82% |
| March 31, 2015 | 65.39% |
| December 31, 2014 | 61.87% |
| September 30, 2014 | 66.32% |
| June 30, 2014 | 69.46% |
| March 31, 2014 | 70.95% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Novo Nordisk A/S | 78.21% |
| ALK-Abello A/S | 66.57% |
| AstraZeneca PLC | 76.09% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 15.36% |
| Return on Assets | 7.37% |
| Return on Invested Capital | 10.53% |
| Profit Margin (Quarterly) | 17.61% |
| Operating Margin (Quarterly) | 23.67% |
| Return on Net Operating Assets | 8.83% |